Evidence map›Paper›PMID 36769214›Full record

ReviewInternational journal of molecular sciences2023

Silvia Salvatori, Irene Marafini, Federica Laudisi, Giovanni Monteleone, Carmine Stolfi

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 144 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
144citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

144 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Frontiers in medicine · 2024
    Pooled it
  3. Pooled it
  4. AdjuvantMicrobiology spectrum · 2026
    Trial
  5. Eradication ofHealth technology assessment (Winchester, England) · 2025
    Trial
  6. Advances inOncology letters · 2026
    Review
  7. Cuproplasia-associated LOXL2 cooperates withJournal of gastrointestinal oncology · 2026
    Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. International journal of molecular medicine · 2026
    Review
  19. Article
  20. Article

84 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Silvia SalvatoriDepartment of Systems Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0002-4980-6289
Irene MarafiniDepartment of Systems Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
Federica LaudisiDepartment of Systems Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0001-7380-0269
Giovanni MonteleoneDepartment of Systems Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0003-1339-9076
Carmine StolfiDepartment of Systems Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0002-6354-2443

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer is the sixth most commonly diagnosed cancer and the fourth leading cause of cancer death worldwide.

Indexed as

Helicobacter InfectionsHelicobacter pyloriStomach NeoplasmsAntigens, BacterialBacterial ProteinsGastric MucosaHumansAntigens, BacterialBacterial ProteinsCagAcytokinesgenomic instabilityinflammationMMRROSvirulence factors

Identifiers

PMID36769214
PMCPMC9917787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.